Plain-English translation of NCT06061627 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial tests whether a newer pacing technique called left bundle branch area pacing (LBBAP) works better than the traditional approach for people with heart failure and a specific type of heart rhythm problem called nonspecific intraventricular conduction delay. Both approaches involve surgically implanting a heart device with pacing leads, but they place the leads in different locations in the heart. The study wants to see which method better improves how well the heart pumps.
The newer pacing technique has shown promise in some heart failure patients, but doctors aren't sure if it helps patients with this particular type of conduction delay as well as it helps others. This trial is designed to answer that question and find the best treatment approach for this group of patients.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo surgery to have a heart device implanted with pacing leads placed in your heart. You will be randomly assigned to receive either the newer left bundle branch area pacing approach or the traditional dual-lead pacing approach. After implantation, you will have follow-up visits to monitor how well the device is working and how your heart function has improved, allowing doctors to compare the two techniques over time.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China